Back

A qualitative phase I study protocol on developing patient-reported outcome measure for hair, scalp, eyebrows, eyelashes, and beard-related skin disorders

Chang, Y.-F.; Drake, L.; Reyes-Hadsall, S.; Barbieri, J.; Mostaghimi, A.

2022-08-16 dermatology
10.1101/2022.08.14.22278626 medRxiv
Show abstract

IntroductionHair disorders can have both physical and psychosocial effects significantly impacting patients quality of life. Well-designed patient-reported outcome measures (PROMs) are vital to determine meaningful patient-centered management. Currently available PROMs for individual hair disorders are available, however, making it difficult to use across diseases. This phase I protocol aims to create a clinically meaningful hair assessment across multiple hair disorders that evaluate the patients reported assessment of their disease, its symptoms, and impact on their quality of life, as well as defining characteristics of their desired outcome. Methods and analysisThis phase I study, we will use thematic analysis of qualitative semi-structured interviews. Participants aged 18 years and older, a sampling of patients diagnosed with alopecia areata, androgenic alopecia, lichen planopilaris, central centrifugal cicatricial alopecia, and sebopsoriasis will be invited to take part in qualitative interviews. Participants recruitment and interviews will continue iteratively until thematic saturation is reached, with a focus on interview quality and patient diversity in gender, race and ethnicity, age, and hair-related disorder. The open-ended interview questions will allow participants to reflect on their physical appearance, disease journey, and treatment goals, as well as define the associated physical symptoms and psychosocial impact. These predominant domains will be used to form the basis for a hair-related PROM that can be applied to a multitude of hair-related disorders. Ethics and disseminationThe Brigham and Womens Hospital Institutional Review Board (2022P001033) approved this study. Following the description of the study protocol, we obtained verbal consent from all the study participants. All personal information, interview responses, and medical records are confidential and are stored in an encrypted database. Findings from this study will be published in peer-reviewed journals and presented at dermatology conferences. This is an open access article with Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, that permits others to distribute, remix, and build upon the licensed work non-commercially, and require attribution to the original authors. See https://creativecommons.org/licenses/by-nc/4.0/ for details. Strengths and limitations of this studyO_LIRecruitment of participants with common scarring and non-scarring hair-related disorders will make it possible to establish patients perspectives on physical appearance, definitions of treatment success, physical signs and symptoms, psychological and social impact across multiple disease states involving hair, scalp, eyebrows, eyelashes, and beard. C_LIO_LIInclusion of patients from a wide range of demographics such as age, gender, race, and ethnicity will enable identification of domains common across these differing backgrounds. C_LIO_LIWe adhere to published guidelines for determining validity of scales. C_LIO_LIWe aim to use modern psychometric approach to ensure this study are clinically meaningful. C_LI

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Experimental Dermatology
10 papers in training set
Top 0.1%
34.3%
2
PLOS ONE
4510 papers in training set
Top 17%
10.5%
3
Journal of Investigative Dermatology
42 papers in training set
Top 0.1%
10.5%
50% of probability mass above
4
Frontiers in Medicine
113 papers in training set
Top 0.4%
7.5%
5
BMJ Open
554 papers in training set
Top 4%
5.0%
6
Frontiers in Immunology
586 papers in training set
Top 3%
2.0%
7
PLOS Neglected Tropical Diseases
378 papers in training set
Top 3%
1.8%
8
Frontiers in Public Health
140 papers in training set
Top 4%
1.8%
9
eClinicalMedicine
55 papers in training set
Top 0.5%
1.7%
10
Cureus
67 papers in training set
Top 3%
1.5%
11
PLOS Medicine
98 papers in training set
Top 3%
1.5%
12
Scientific Reports
3102 papers in training set
Top 63%
1.4%
13
JAMA Network Open
127 papers in training set
Top 3%
1.4%
14
Eye
11 papers in training set
Top 0.3%
1.4%
15
Nature Communications
4913 papers in training set
Top 55%
1.3%
16
The FASEB Journal
175 papers in training set
Top 2%
1.3%
17
Frontiers in Nutrition
23 papers in training set
Top 0.9%
1.3%
18
RMD Open
13 papers in training set
Top 0.2%
1.3%
19
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 0.7%
1.3%
20
Tropical Medicine and Infectious Disease
12 papers in training set
Top 0.2%
1.3%
21
BMC Cancer
52 papers in training set
Top 2%
1.0%
22
Scientific Data
174 papers in training set
Top 2%
1.0%
23
Blood Advances
54 papers in training set
Top 1.0%
1.0%
24
JCI Insight
241 papers in training set
Top 6%
0.9%
25
Human Genomics
21 papers in training set
Top 0.4%
0.7%
26
European Journal of Cancer
10 papers in training set
Top 0.6%
0.7%